arBtrage CAPITALIZING MARKETS checking… Sign in

Merck & Company, Inc.

MRK Health Care Biotechnology: Pharmaceutical Preparations
$120.79
▲ +0.4% Today
as of Jun 7, 07:21 ET
Last 30 days +9.78% Apr 28 → Jun 05
$108.12 $111.96 $115.80 $119.63 $123.47 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$120.94
High
$123.45
Low
$120.36
Volume
$9M
Avg Vol
$12M
Mkt Cap
$296.1B
P/E (TTM)
51.18
Beta
52w High
$125.14
52w Low
$76.66
Div Yield
Shares Out

Overview

52-week range
$77
$125
91% of range
Avg surprise (last 1)
+3.3%
Avg reaction (last 1)
+1.4%
100% positive
Latest IV / EM
34%
EM ±3.2% · $121 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.35$-1.18$-0.02$1.15$2.32 Actual $-2.35Actual $1.86Actual $1.87Actual $2.14Actual $1.24Actual $2.22Est $2.15Actual $1.76Actual $2.32Actual $-1.72 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-4.2B$1.4B$6.9B$12.5B$18.1B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $-1.72 financials
Tue Sep 30, 2025Sep 2025 $2.32 financials
Mon Jun 30, 2025Jun 2025 $1.76 financials
Thu Apr 24, 2025Mar/2025 $2.22 $2.15 +3.3% +1.4% earnings
Mon Sep 30, 2024Sep 2024 $1.24 financials
Sun Jun 30, 2024Jun 2024 $2.14 financials
Sun Mar 31, 2024Mar 2024 $1.87 financials
Sat Sep 30, 2023Sep 2023 $1.86 financials
Fri Jun 30, 2023Jun 2023 $-2.35 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$16.29B$17.28B$15.81B$15.53B$16.66B$16.11B
Cost of revenue$4.20B$3.85B$3.56B$3.42B$4.08B$3.75B
Gross profit
Operating income
Net income$-4.24B$5.79B$4.43B$5.08B$3.16B$5.46B
EPS (diluted)$-1.72$2.32$1.76$2.01$1.24$2.14

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$5.33B$14.56B$18.17B$8.01B$8.63B$13.24B$14.59B$11.30B
Inventory$6.48B$6.66B$6.44B$6.60B$6.20B$6.11B$6.24B$6.47B
Total current assets$35.02B$43.52B$47.56B$37.06B$35.50B$38.78B$40.36B$38.20B
Total assets$128.69B$136.87B$129.55B$117.52B$115.12B$117.11B$117.53B$112.63B
Long-term debt$46.67B$46.75B$39.97B$33.97B$33.48B$34.46B$34.98B$34.72B
Total liabilities
Total equity$45.88B$52.61B$51.85B$48.99B$48.34B$46.31B$44.50B$43.58B

Implied volatility — last 90 days

28%31%33%36%38% Jun 07 — IV 34% · EM ±3.2%

Sector peers